Sherbrooke Park Advisers’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,047
Closed -$596K 552
2025
Q1
$596K Buy
4,047
+94
+2% +$14.4K 0.28% 92
2024
Q4
$642K Buy
+3,953
New +$647K 0.2% 140
2024
Q2
Sell
-5,397
Closed -$826K 946
2024
Q1
$826K Buy
+5,397
New +$806K 0.16% 200
2023
Q4
Sell
-14,252
Closed -$1.87M 489
2023
Q3
$1.87M Buy
14,252
+10,652
+296% +$1.62M 0.59% 17
2023
Q2
$573K Buy
3,600
+800
+29% +$129K 0.3% 140
2023
Q1
$443K Buy
2,800
+1,000
+56% +$150K 0.67% 41
2022
Q4
$253K Buy
+1,800
New +$255K 0.18% 212

Other funds holding CLX

Sherbrooke Park Advisers's CLX Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Clorox (CLX) in Q2 2025, closing a stake of 4,047 shares — an estimated $596K sold.

Sherbrooke Park Advisers first reported a position in CLX in Q4 2022 and held it in 7 quarters. The position peaked at $1.87M in Q3 2023. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 4,047 Clorox shares in Q2 2025, an estimated $596K.
  • Sherbrooke Park Advisers first reported a position in Clorox in Q4 2022 and held it in 7 quarters.
  • Sherbrooke Park Advisers's Clorox position peaked at $1.87M in Q3 2023.
  • 1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.